nodes	percent_of_prediction	percent_of_DWPC	metapath
Flecainide—CYP2D6—breast cancer	0.306	1	CbGaD
Flecainide—CYP2C9—Anastrozole—breast cancer	0.0739	0.213	CbGbCtD
Flecainide—CYP2C9—Idarubicin—breast cancer	0.056	0.162	CbGbCtD
Flecainide—CYP2D6—Idarubicin—breast cancer	0.0512	0.148	CbGbCtD
Flecainide—CYP2C9—Capecitabine—breast cancer	0.0307	0.0886	CbGbCtD
Flecainide—CYP2D6—Vinorelbine—breast cancer	0.025	0.0722	CbGbCtD
Flecainide—CYP2C9—Tamoxifen—breast cancer	0.0247	0.0713	CbGbCtD
Flecainide—CYP2D6—Tamoxifen—breast cancer	0.0226	0.0652	CbGbCtD
Flecainide—CYP2C9—Paclitaxel—breast cancer	0.0192	0.0555	CbGbCtD
Flecainide—CYP2C9—Fluorouracil—breast cancer	0.0182	0.0525	CbGbCtD
Flecainide—CYP2D6—Vinblastine—breast cancer	0.0154	0.0445	CbGbCtD
Flecainide—CYP2D6—Doxorubicin—breast cancer	0.00947	0.0273	CbGbCtD
Flecainide—Mefloquine—HBA1—breast cancer	0.005	0.481	CrCbGaD
Flecainide—Mefloquine—ACHE—breast cancer	0.00179	0.172	CrCbGaD
Flecainide—Mefloquine—CYP19A1—breast cancer	0.00106	0.102	CrCbGaD
Flecainide—Mefloquine—BCHE—breast cancer	0.00105	0.101	CrCbGaD
Flecainide—Mefloquine—CYP2D6—breast cancer	0.000579	0.0557	CrCbGaD
Flecainide—Mefloquine—CYP3A4—breast cancer	0.000496	0.0477	CrCbGaD
Flecainide—Mefloquine—ABCB1—breast cancer	0.000413	0.0397	CrCbGaD
Flecainide—Visual impairment—Epirubicin—breast cancer	7.15e-05	0.000265	CcSEcCtD
Flecainide—Agranulocytosis—Doxorubicin—breast cancer	7.13e-05	0.000265	CcSEcCtD
Flecainide—Rash—Mitoxantrone—breast cancer	7.13e-05	0.000265	CcSEcCtD
Flecainide—Rash—Irinotecan—breast cancer	7.13e-05	0.000265	CcSEcCtD
Flecainide—Dermatitis—Irinotecan—breast cancer	7.12e-05	0.000264	CcSEcCtD
Flecainide—Dermatitis—Mitoxantrone—breast cancer	7.12e-05	0.000264	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Docetaxel—breast cancer	7.12e-05	0.000264	CcSEcCtD
Flecainide—Headache—Mitoxantrone—breast cancer	7.08e-05	0.000263	CcSEcCtD
Flecainide—Headache—Irinotecan—breast cancer	7.08e-05	0.000263	CcSEcCtD
Flecainide—Hypotension—Capecitabine—breast cancer	7.07e-05	0.000262	CcSEcCtD
Flecainide—Insomnia—Docetaxel—breast cancer	7.07e-05	0.000262	CcSEcCtD
Flecainide—Paraesthesia—Docetaxel—breast cancer	7.01e-05	0.00026	CcSEcCtD
Flecainide—Alopecia—Methotrexate—breast cancer	7e-05	0.00026	CcSEcCtD
Flecainide—Vomiting—Gemcitabine—breast cancer	7e-05	0.00026	CcSEcCtD
Flecainide—Bradycardia—Doxorubicin—breast cancer	6.99e-05	0.000259	CcSEcCtD
Flecainide—Dyspnoea—Docetaxel—breast cancer	6.96e-05	0.000259	CcSEcCtD
Flecainide—Somnolence—Docetaxel—breast cancer	6.95e-05	0.000258	CcSEcCtD
Flecainide—Rash—Gemcitabine—breast cancer	6.94e-05	0.000258	CcSEcCtD
Flecainide—Dermatitis—Gemcitabine—breast cancer	6.93e-05	0.000257	CcSEcCtD
Flecainide—Eye disorder—Epirubicin—breast cancer	6.93e-05	0.000257	CcSEcCtD
Flecainide—Tinnitus—Epirubicin—breast cancer	6.92e-05	0.000257	CcSEcCtD
Flecainide—Headache—Gemcitabine—breast cancer	6.9e-05	0.000256	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Capecitabine—breast cancer	6.89e-05	0.000256	CcSEcCtD
Flecainide—Flushing—Epirubicin—breast cancer	6.88e-05	0.000256	CcSEcCtD
Flecainide—Vomiting—Fluorouracil—breast cancer	6.88e-05	0.000256	CcSEcCtD
Flecainide—Dyspepsia—Docetaxel—breast cancer	6.88e-05	0.000255	CcSEcCtD
Flecainide—Insomnia—Capecitabine—breast cancer	6.84e-05	0.000254	CcSEcCtD
Flecainide—Hypoaesthesia—Doxorubicin—breast cancer	6.83e-05	0.000254	CcSEcCtD
Flecainide—Rash—Fluorouracil—breast cancer	6.82e-05	0.000253	CcSEcCtD
Flecainide—Dermatitis—Fluorouracil—breast cancer	6.82e-05	0.000253	CcSEcCtD
Flecainide—Paraesthesia—Capecitabine—breast cancer	6.79e-05	0.000252	CcSEcCtD
Flecainide—Decreased appetite—Docetaxel—breast cancer	6.79e-05	0.000252	CcSEcCtD
Flecainide—Headache—Fluorouracil—breast cancer	6.78e-05	0.000252	CcSEcCtD
Flecainide—Dysgeusia—Methotrexate—breast cancer	6.76e-05	0.000251	CcSEcCtD
Flecainide—Gastrointestinal disorder—Docetaxel—breast cancer	6.74e-05	0.00025	CcSEcCtD
Flecainide—Dyspnoea—Capecitabine—breast cancer	6.74e-05	0.00025	CcSEcCtD
Flecainide—Fatigue—Docetaxel—breast cancer	6.74e-05	0.00025	CcSEcCtD
Flecainide—Nausea—Mitoxantrone—breast cancer	6.71e-05	0.000249	CcSEcCtD
Flecainide—Nausea—Irinotecan—breast cancer	6.71e-05	0.000249	CcSEcCtD
Flecainide—Immune system disorder—Epirubicin—breast cancer	6.7e-05	0.000249	CcSEcCtD
Flecainide—Pain—Docetaxel—breast cancer	6.68e-05	0.000248	CcSEcCtD
Flecainide—Constipation—Docetaxel—breast cancer	6.68e-05	0.000248	CcSEcCtD
Flecainide—Dyspepsia—Capecitabine—breast cancer	6.66e-05	0.000247	CcSEcCtD
Flecainide—Visual impairment—Doxorubicin—breast cancer	6.61e-05	0.000246	CcSEcCtD
Flecainide—Asthenia—Paclitaxel—breast cancer	6.61e-05	0.000246	CcSEcCtD
Flecainide—Decreased appetite—Capecitabine—breast cancer	6.58e-05	0.000244	CcSEcCtD
Flecainide—Alopecia—Epirubicin—breast cancer	6.55e-05	0.000243	CcSEcCtD
Flecainide—Nausea—Gemcitabine—breast cancer	6.54e-05	0.000243	CcSEcCtD
Flecainide—Gastrointestinal disorder—Capecitabine—breast cancer	6.53e-05	0.000242	CcSEcCtD
Flecainide—Fatigue—Capecitabine—breast cancer	6.52e-05	0.000242	CcSEcCtD
Flecainide—Pruritus—Paclitaxel—breast cancer	6.52e-05	0.000242	CcSEcCtD
Flecainide—Vision blurred—Methotrexate—breast cancer	6.5e-05	0.000241	CcSEcCtD
Flecainide—Constipation—Capecitabine—breast cancer	6.47e-05	0.00024	CcSEcCtD
Flecainide—Pain—Capecitabine—breast cancer	6.47e-05	0.00024	CcSEcCtD
Flecainide—Feeling abnormal—Docetaxel—breast cancer	6.44e-05	0.000239	CcSEcCtD
Flecainide—Nausea—Fluorouracil—breast cancer	6.43e-05	0.000239	CcSEcCtD
Flecainide—Eye disorder—Doxorubicin—breast cancer	6.41e-05	0.000238	CcSEcCtD
Flecainide—Ill-defined disorder—Methotrexate—breast cancer	6.4e-05	0.000238	CcSEcCtD
Flecainide—Tinnitus—Doxorubicin—breast cancer	6.4e-05	0.000238	CcSEcCtD
Flecainide—Gastrointestinal pain—Docetaxel—breast cancer	6.39e-05	0.000237	CcSEcCtD
Flecainide—Flushing—Doxorubicin—breast cancer	6.37e-05	0.000236	CcSEcCtD
Flecainide—Flatulence—Epirubicin—breast cancer	6.36e-05	0.000236	CcSEcCtD
Flecainide—Tension—Epirubicin—breast cancer	6.34e-05	0.000235	CcSEcCtD
Flecainide—Dysgeusia—Epirubicin—breast cancer	6.32e-05	0.000235	CcSEcCtD
Flecainide—Diarrhoea—Paclitaxel—breast cancer	6.31e-05	0.000234	CcSEcCtD
Flecainide—Nervousness—Epirubicin—breast cancer	6.27e-05	0.000233	CcSEcCtD
Flecainide—Feeling abnormal—Capecitabine—breast cancer	6.23e-05	0.000231	CcSEcCtD
Flecainide—Malaise—Methotrexate—breast cancer	6.22e-05	0.000231	CcSEcCtD
Flecainide—Immune system disorder—Doxorubicin—breast cancer	6.2e-05	0.00023	CcSEcCtD
Flecainide—Vertigo—Methotrexate—breast cancer	6.2e-05	0.00023	CcSEcCtD
Flecainide—Gastrointestinal pain—Capecitabine—breast cancer	6.19e-05	0.00023	CcSEcCtD
Flecainide—Body temperature increased—Docetaxel—breast cancer	6.18e-05	0.000229	CcSEcCtD
Flecainide—Abdominal pain—Docetaxel—breast cancer	6.18e-05	0.000229	CcSEcCtD
Flecainide—Leukopenia—Methotrexate—breast cancer	6.18e-05	0.000229	CcSEcCtD
Flecainide—Dizziness—Paclitaxel—breast cancer	6.09e-05	0.000226	CcSEcCtD
Flecainide—Vision blurred—Epirubicin—breast cancer	6.08e-05	0.000226	CcSEcCtD
Flecainide—Alopecia—Doxorubicin—breast cancer	6.06e-05	0.000225	CcSEcCtD
Flecainide—Cough—Methotrexate—breast cancer	6.02e-05	0.000224	CcSEcCtD
Flecainide—Urticaria—Capecitabine—breast cancer	6.01e-05	0.000223	CcSEcCtD
Flecainide—Ill-defined disorder—Epirubicin—breast cancer	5.99e-05	0.000222	CcSEcCtD
Flecainide—Abdominal pain—Capecitabine—breast cancer	5.98e-05	0.000222	CcSEcCtD
Flecainide—Body temperature increased—Capecitabine—breast cancer	5.98e-05	0.000222	CcSEcCtD
Flecainide—Convulsion—Methotrexate—breast cancer	5.98e-05	0.000222	CcSEcCtD
Flecainide—Flatulence—Doxorubicin—breast cancer	5.89e-05	0.000219	CcSEcCtD
Flecainide—Chest pain—Methotrexate—breast cancer	5.87e-05	0.000218	CcSEcCtD
Flecainide—Arthralgia—Methotrexate—breast cancer	5.87e-05	0.000218	CcSEcCtD
Flecainide—Myalgia—Methotrexate—breast cancer	5.87e-05	0.000218	CcSEcCtD
Flecainide—Tension—Doxorubicin—breast cancer	5.86e-05	0.000218	CcSEcCtD
Flecainide—Vomiting—Paclitaxel—breast cancer	5.86e-05	0.000218	CcSEcCtD
Flecainide—Dysgeusia—Doxorubicin—breast cancer	5.85e-05	0.000217	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	5.83e-05	0.000217	CcSEcCtD
Flecainide—Malaise—Epirubicin—breast cancer	5.82e-05	0.000216	CcSEcCtD
Flecainide—Rash—Paclitaxel—breast cancer	5.81e-05	0.000216	CcSEcCtD
Flecainide—Dermatitis—Paclitaxel—breast cancer	5.81e-05	0.000216	CcSEcCtD
Flecainide—Discomfort—Methotrexate—breast cancer	5.8e-05	0.000215	CcSEcCtD
Flecainide—Nervousness—Doxorubicin—breast cancer	5.8e-05	0.000215	CcSEcCtD
Flecainide—Vertigo—Epirubicin—breast cancer	5.8e-05	0.000215	CcSEcCtD
Flecainide—Syncope—Epirubicin—breast cancer	5.79e-05	0.000215	CcSEcCtD
Flecainide—Leukopenia—Epirubicin—breast cancer	5.78e-05	0.000215	CcSEcCtD
Flecainide—Headache—Paclitaxel—breast cancer	5.77e-05	0.000214	CcSEcCtD
Flecainide—Palpitations—Epirubicin—breast cancer	5.71e-05	0.000212	CcSEcCtD
Flecainide—Confusional state—Methotrexate—breast cancer	5.68e-05	0.000211	CcSEcCtD
Flecainide—Loss of consciousness—Epirubicin—breast cancer	5.67e-05	0.000211	CcSEcCtD
Flecainide—Cough—Epirubicin—breast cancer	5.63e-05	0.000209	CcSEcCtD
Flecainide—Vision blurred—Doxorubicin—breast cancer	5.63e-05	0.000209	CcSEcCtD
Flecainide—Asthenia—Docetaxel—breast cancer	5.61e-05	0.000208	CcSEcCtD
Flecainide—Convulsion—Epirubicin—breast cancer	5.59e-05	0.000208	CcSEcCtD
Flecainide—Hypertension—Epirubicin—breast cancer	5.57e-05	0.000207	CcSEcCtD
Flecainide—Ill-defined disorder—Doxorubicin—breast cancer	5.54e-05	0.000206	CcSEcCtD
Flecainide—Pruritus—Docetaxel—breast cancer	5.53e-05	0.000205	CcSEcCtD
Flecainide—Nervous system disorder—Methotrexate—breast cancer	5.52e-05	0.000205	CcSEcCtD
Flecainide—Thrombocytopenia—Methotrexate—breast cancer	5.51e-05	0.000205	CcSEcCtD
Flecainide—Chest pain—Epirubicin—breast cancer	5.5e-05	0.000204	CcSEcCtD
Flecainide—Arthralgia—Epirubicin—breast cancer	5.5e-05	0.000204	CcSEcCtD
Flecainide—Myalgia—Epirubicin—breast cancer	5.5e-05	0.000204	CcSEcCtD
Flecainide—Anxiety—Epirubicin—breast cancer	5.48e-05	0.000203	CcSEcCtD
Flecainide—Nausea—Paclitaxel—breast cancer	5.47e-05	0.000203	CcSEcCtD
Flecainide—Skin disorder—Methotrexate—breast cancer	5.47e-05	0.000203	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	5.46e-05	0.000203	CcSEcCtD
Flecainide—Hyperhidrosis—Methotrexate—breast cancer	5.44e-05	0.000202	CcSEcCtD
Flecainide—Discomfort—Epirubicin—breast cancer	5.43e-05	0.000202	CcSEcCtD
Flecainide—Asthenia—Capecitabine—breast cancer	5.43e-05	0.000202	CcSEcCtD
Flecainide—Malaise—Doxorubicin—breast cancer	5.39e-05	0.0002	CcSEcCtD
Flecainide—Dry mouth—Epirubicin—breast cancer	5.38e-05	0.0002	CcSEcCtD
Flecainide—Vertigo—Doxorubicin—breast cancer	5.37e-05	0.000199	CcSEcCtD
Flecainide—Anorexia—Methotrexate—breast cancer	5.37e-05	0.000199	CcSEcCtD
Flecainide—Syncope—Doxorubicin—breast cancer	5.36e-05	0.000199	CcSEcCtD
Flecainide—Pruritus—Capecitabine—breast cancer	5.35e-05	0.000199	CcSEcCtD
Flecainide—Leukopenia—Doxorubicin—breast cancer	5.35e-05	0.000199	CcSEcCtD
Flecainide—Diarrhoea—Docetaxel—breast cancer	5.35e-05	0.000198	CcSEcCtD
Flecainide—Confusional state—Epirubicin—breast cancer	5.31e-05	0.000197	CcSEcCtD
Flecainide—Palpitations—Doxorubicin—breast cancer	5.28e-05	0.000196	CcSEcCtD
Flecainide—Oedema—Epirubicin—breast cancer	5.27e-05	0.000196	CcSEcCtD
Flecainide—Hypotension—Methotrexate—breast cancer	5.26e-05	0.000195	CcSEcCtD
Flecainide—Loss of consciousness—Doxorubicin—breast cancer	5.25e-05	0.000195	CcSEcCtD
Flecainide—Cough—Doxorubicin—breast cancer	5.21e-05	0.000194	CcSEcCtD
Flecainide—Shock—Epirubicin—breast cancer	5.18e-05	0.000192	CcSEcCtD
Flecainide—Convulsion—Doxorubicin—breast cancer	5.18e-05	0.000192	CcSEcCtD
Flecainide—Diarrhoea—Capecitabine—breast cancer	5.18e-05	0.000192	CcSEcCtD
Flecainide—Nervous system disorder—Epirubicin—breast cancer	5.17e-05	0.000192	CcSEcCtD
Flecainide—Dizziness—Docetaxel—breast cancer	5.17e-05	0.000192	CcSEcCtD
Flecainide—Thrombocytopenia—Epirubicin—breast cancer	5.16e-05	0.000192	CcSEcCtD
Flecainide—Hypertension—Doxorubicin—breast cancer	5.16e-05	0.000192	CcSEcCtD
Flecainide—Tachycardia—Epirubicin—breast cancer	5.14e-05	0.000191	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Methotrexate—breast cancer	5.13e-05	0.00019	CcSEcCtD
Flecainide—Skin disorder—Epirubicin—breast cancer	5.12e-05	0.00019	CcSEcCtD
Flecainide—Hyperhidrosis—Epirubicin—breast cancer	5.09e-05	0.000189	CcSEcCtD
Flecainide—Insomnia—Methotrexate—breast cancer	5.09e-05	0.000189	CcSEcCtD
Flecainide—Chest pain—Doxorubicin—breast cancer	5.09e-05	0.000189	CcSEcCtD
Flecainide—Arthralgia—Doxorubicin—breast cancer	5.09e-05	0.000189	CcSEcCtD
Flecainide—Myalgia—Doxorubicin—breast cancer	5.09e-05	0.000189	CcSEcCtD
Flecainide—Anxiety—Doxorubicin—breast cancer	5.07e-05	0.000188	CcSEcCtD
Flecainide—Paraesthesia—Methotrexate—breast cancer	5.06e-05	0.000188	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	5.05e-05	0.000188	CcSEcCtD
Flecainide—Discomfort—Doxorubicin—breast cancer	5.03e-05	0.000187	CcSEcCtD
Flecainide—Anorexia—Epirubicin—breast cancer	5.02e-05	0.000187	CcSEcCtD
Flecainide—Dyspnoea—Methotrexate—breast cancer	5.02e-05	0.000186	CcSEcCtD
Flecainide—Somnolence—Methotrexate—breast cancer	5.01e-05	0.000186	CcSEcCtD
Flecainide—Dizziness—Capecitabine—breast cancer	5e-05	0.000186	CcSEcCtD
Flecainide—Dry mouth—Doxorubicin—breast cancer	4.97e-05	0.000185	CcSEcCtD
Flecainide—Vomiting—Docetaxel—breast cancer	4.97e-05	0.000184	CcSEcCtD
Flecainide—Dyspepsia—Methotrexate—breast cancer	4.96e-05	0.000184	CcSEcCtD
Flecainide—Rash—Docetaxel—breast cancer	4.93e-05	0.000183	CcSEcCtD
Flecainide—Hypotension—Epirubicin—breast cancer	4.92e-05	0.000183	CcSEcCtD
Flecainide—Dermatitis—Docetaxel—breast cancer	4.92e-05	0.000183	CcSEcCtD
Flecainide—Confusional state—Doxorubicin—breast cancer	4.92e-05	0.000183	CcSEcCtD
Flecainide—Decreased appetite—Methotrexate—breast cancer	4.89e-05	0.000182	CcSEcCtD
Flecainide—Headache—Docetaxel—breast cancer	4.89e-05	0.000182	CcSEcCtD
Flecainide—Oedema—Doxorubicin—breast cancer	4.88e-05	0.000181	CcSEcCtD
Flecainide—Gastrointestinal disorder—Methotrexate—breast cancer	4.86e-05	0.000181	CcSEcCtD
Flecainide—Fatigue—Methotrexate—breast cancer	4.85e-05	0.00018	CcSEcCtD
Flecainide—Pain—Methotrexate—breast cancer	4.82e-05	0.000179	CcSEcCtD
Flecainide—Vomiting—Capecitabine—breast cancer	4.81e-05	0.000179	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Epirubicin—breast cancer	4.8e-05	0.000178	CcSEcCtD
Flecainide—Shock—Doxorubicin—breast cancer	4.8e-05	0.000178	CcSEcCtD
Flecainide—Nervous system disorder—Doxorubicin—breast cancer	4.78e-05	0.000178	CcSEcCtD
Flecainide—Thrombocytopenia—Doxorubicin—breast cancer	4.77e-05	0.000177	CcSEcCtD
Flecainide—Rash—Capecitabine—breast cancer	4.77e-05	0.000177	CcSEcCtD
Flecainide—Insomnia—Epirubicin—breast cancer	4.77e-05	0.000177	CcSEcCtD
Flecainide—Dermatitis—Capecitabine—breast cancer	4.76e-05	0.000177	CcSEcCtD
Flecainide—Tachycardia—Doxorubicin—breast cancer	4.76e-05	0.000177	CcSEcCtD
Flecainide—Headache—Capecitabine—breast cancer	4.74e-05	0.000176	CcSEcCtD
Flecainide—Skin disorder—Doxorubicin—breast cancer	4.74e-05	0.000176	CcSEcCtD
Flecainide—Paraesthesia—Epirubicin—breast cancer	4.73e-05	0.000176	CcSEcCtD
Flecainide—Hyperhidrosis—Doxorubicin—breast cancer	4.71e-05	0.000175	CcSEcCtD
Flecainide—Dyspnoea—Epirubicin—breast cancer	4.7e-05	0.000174	CcSEcCtD
Flecainide—Somnolence—Epirubicin—breast cancer	4.68e-05	0.000174	CcSEcCtD
Flecainide—Anorexia—Doxorubicin—breast cancer	4.65e-05	0.000173	CcSEcCtD
Flecainide—Nausea—Docetaxel—breast cancer	4.64e-05	0.000172	CcSEcCtD
Flecainide—Feeling abnormal—Methotrexate—breast cancer	4.64e-05	0.000172	CcSEcCtD
Flecainide—Dyspepsia—Epirubicin—breast cancer	4.64e-05	0.000172	CcSEcCtD
Flecainide—Gastrointestinal pain—Methotrexate—breast cancer	4.6e-05	0.000171	CcSEcCtD
Flecainide—Decreased appetite—Epirubicin—breast cancer	4.58e-05	0.00017	CcSEcCtD
Flecainide—Hypotension—Doxorubicin—breast cancer	4.56e-05	0.000169	CcSEcCtD
Flecainide—Gastrointestinal disorder—Epirubicin—breast cancer	4.55e-05	0.000169	CcSEcCtD
Flecainide—Fatigue—Epirubicin—breast cancer	4.54e-05	0.000169	CcSEcCtD
Flecainide—Pain—Epirubicin—breast cancer	4.51e-05	0.000167	CcSEcCtD
Flecainide—Constipation—Epirubicin—breast cancer	4.51e-05	0.000167	CcSEcCtD
Flecainide—Nausea—Capecitabine—breast cancer	4.49e-05	0.000167	CcSEcCtD
Flecainide—Urticaria—Methotrexate—breast cancer	4.47e-05	0.000166	CcSEcCtD
Flecainide—Body temperature increased—Methotrexate—breast cancer	4.45e-05	0.000165	CcSEcCtD
Flecainide—Abdominal pain—Methotrexate—breast cancer	4.45e-05	0.000165	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Doxorubicin—breast cancer	4.44e-05	0.000165	CcSEcCtD
Flecainide—Insomnia—Doxorubicin—breast cancer	4.41e-05	0.000164	CcSEcCtD
Flecainide—Paraesthesia—Doxorubicin—breast cancer	4.38e-05	0.000163	CcSEcCtD
Flecainide—Dyspnoea—Doxorubicin—breast cancer	4.35e-05	0.000161	CcSEcCtD
Flecainide—Feeling abnormal—Epirubicin—breast cancer	4.34e-05	0.000161	CcSEcCtD
Flecainide—Somnolence—Doxorubicin—breast cancer	4.33e-05	0.000161	CcSEcCtD
Flecainide—Gastrointestinal pain—Epirubicin—breast cancer	4.31e-05	0.00016	CcSEcCtD
Flecainide—Dyspepsia—Doxorubicin—breast cancer	4.29e-05	0.000159	CcSEcCtD
Flecainide—Decreased appetite—Doxorubicin—breast cancer	4.24e-05	0.000157	CcSEcCtD
Flecainide—Gastrointestinal disorder—Doxorubicin—breast cancer	4.21e-05	0.000156	CcSEcCtD
Flecainide—Fatigue—Doxorubicin—breast cancer	4.2e-05	0.000156	CcSEcCtD
Flecainide—Urticaria—Epirubicin—breast cancer	4.19e-05	0.000155	CcSEcCtD
Flecainide—Constipation—Doxorubicin—breast cancer	4.17e-05	0.000155	CcSEcCtD
Flecainide—Pain—Doxorubicin—breast cancer	4.17e-05	0.000155	CcSEcCtD
Flecainide—Body temperature increased—Epirubicin—breast cancer	4.17e-05	0.000155	CcSEcCtD
Flecainide—Abdominal pain—Epirubicin—breast cancer	4.17e-05	0.000155	CcSEcCtD
Flecainide—Asthenia—Methotrexate—breast cancer	4.04e-05	0.00015	CcSEcCtD
Flecainide—Feeling abnormal—Doxorubicin—breast cancer	4.02e-05	0.000149	CcSEcCtD
Flecainide—Gastrointestinal pain—Doxorubicin—breast cancer	3.99e-05	0.000148	CcSEcCtD
Flecainide—Pruritus—Methotrexate—breast cancer	3.98e-05	0.000148	CcSEcCtD
Flecainide—Urticaria—Doxorubicin—breast cancer	3.87e-05	0.000144	CcSEcCtD
Flecainide—Abdominal pain—Doxorubicin—breast cancer	3.85e-05	0.000143	CcSEcCtD
Flecainide—Body temperature increased—Doxorubicin—breast cancer	3.85e-05	0.000143	CcSEcCtD
Flecainide—Diarrhoea—Methotrexate—breast cancer	3.85e-05	0.000143	CcSEcCtD
Flecainide—CYP2C9—Biological oxidations—GSTM1—breast cancer	3.8e-05	0.000565	CbGpPWpGaD
Flecainide—Asthenia—Epirubicin—breast cancer	3.78e-05	0.00014	CcSEcCtD
Flecainide—CYP2D6—Metapathway biotransformation—GSTM1—breast cancer	3.78e-05	0.000562	CbGpPWpGaD
Flecainide—CYP2C9—Metapathway biotransformation—GSTM1—breast cancer	3.74e-05	0.000557	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—FHL2—breast cancer	3.73e-05	0.000555	CbGpPWpGaD
Flecainide—Pruritus—Epirubicin—breast cancer	3.73e-05	0.000138	CcSEcCtD
Flecainide—Dizziness—Methotrexate—breast cancer	3.72e-05	0.000138	CcSEcCtD
Flecainide—SCN5A—Axon guidance—MMP9—breast cancer	3.66e-05	0.000545	CbGpPWpGaD
Flecainide—CYP2D6—Biological oxidations—CYP1A1—breast cancer	3.63e-05	0.00054	CbGpPWpGaD
Flecainide—Diarrhoea—Epirubicin—breast cancer	3.61e-05	0.000134	CcSEcCtD
Flecainide—CYP2C9—Biological oxidations—CYP1A1—breast cancer	3.6e-05	0.000535	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—AKT2—breast cancer	3.59e-05	0.000534	CbGpPWpGaD
Flecainide—Vomiting—Methotrexate—breast cancer	3.58e-05	0.000133	CcSEcCtD
Flecainide—CYP2D6—Metapathway biotransformation—CYP1A1—breast cancer	3.58e-05	0.000533	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—SRC—breast cancer	3.56e-05	0.000529	CbGpPWpGaD
Flecainide—Rash—Methotrexate—breast cancer	3.55e-05	0.000132	CcSEcCtD
Flecainide—CYP2C9—Metapathway biotransformation—CYP1A1—breast cancer	3.55e-05	0.000528	CbGpPWpGaD
Flecainide—Dermatitis—Methotrexate—breast cancer	3.55e-05	0.000132	CcSEcCtD
Flecainide—Headache—Methotrexate—breast cancer	3.53e-05	0.000131	CcSEcCtD
Flecainide—SCN4A—Axon guidance—HRAS—breast cancer	3.51e-05	0.000522	CbGpPWpGaD
Flecainide—Asthenia—Doxorubicin—breast cancer	3.5e-05	0.00013	CcSEcCtD
Flecainide—Dizziness—Epirubicin—breast cancer	3.48e-05	0.000129	CcSEcCtD
Flecainide—SCN5A—Developmental Biology—MMP2—breast cancer	3.48e-05	0.000517	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—ABCC1—breast cancer	3.47e-05	0.000516	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—VEGFA—breast cancer	3.46e-05	0.000515	CbGpPWpGaD
Flecainide—Pruritus—Doxorubicin—breast cancer	3.45e-05	0.000128	CcSEcCtD
Flecainide—SCN4A—Developmental Biology—STAT3—breast cancer	3.43e-05	0.00051	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—SRC—breast cancer	3.38e-05	0.000503	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1B—breast cancer	3.36e-05	0.0005	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—IL6—breast cancer	3.36e-05	0.000499	CbGpPWpGaD
Flecainide—Vomiting—Epirubicin—breast cancer	3.35e-05	0.000124	CcSEcCtD
Flecainide—Nausea—Methotrexate—breast cancer	3.34e-05	0.000124	CcSEcCtD
Flecainide—Diarrhoea—Doxorubicin—breast cancer	3.34e-05	0.000124	CcSEcCtD
Flecainide—Rash—Epirubicin—breast cancer	3.32e-05	0.000123	CcSEcCtD
Flecainide—Dermatitis—Epirubicin—breast cancer	3.32e-05	0.000123	CcSEcCtD
Flecainide—Headache—Epirubicin—breast cancer	3.3e-05	0.000123	CcSEcCtD
Flecainide—SCN5A—Axon guidance—VEGFA—breast cancer	3.29e-05	0.000489	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—MAPK3—breast cancer	3.28e-05	0.000487	CbGpPWpGaD
Flecainide—Dizziness—Doxorubicin—breast cancer	3.22e-05	0.00012	CcSEcCtD
Flecainide—SCN4A—Developmental Biology—TGFB1—breast cancer	3.18e-05	0.000473	CbGpPWpGaD
Flecainide—Nausea—Epirubicin—breast cancer	3.13e-05	0.000116	CcSEcCtD
Flecainide—SCN4A—Developmental Biology—EGFR—breast cancer	3.12e-05	0.000464	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—MAPK3—breast cancer	3.11e-05	0.000463	CbGpPWpGaD
Flecainide—Vomiting—Doxorubicin—breast cancer	3.1e-05	0.000115	CcSEcCtD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—GPX2—breast cancer	3.09e-05	0.00046	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—RAF1—breast cancer	3.08e-05	0.000458	CbGpPWpGaD
Flecainide—Rash—Doxorubicin—breast cancer	3.07e-05	0.000114	CcSEcCtD
Flecainide—Dermatitis—Doxorubicin—breast cancer	3.07e-05	0.000114	CcSEcCtD
Flecainide—SCN5A—Developmental Biology—RELA—breast cancer	3.07e-05	0.000456	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—breast cancer	3.06e-05	0.000455	CbGpPWpGaD
Flecainide—Headache—Doxorubicin—breast cancer	3.05e-05	0.000113	CcSEcCtD
Flecainide—SCN5A—Developmental Biology—ERBB2—breast cancer	3.05e-05	0.000453	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—breast cancer	2.98e-05	0.000444	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—TNF—breast cancer	2.97e-05	0.000442	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—EGFR—breast cancer	2.96e-05	0.00044	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—KRAS—breast cancer	2.94e-05	0.000438	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—SYNJ2—breast cancer	2.92e-05	0.000434	CbGpPWpGaD
Flecainide—Nausea—Doxorubicin—breast cancer	2.9e-05	0.000108	CcSEcCtD
Flecainide—CYP2C9—Metabolism—SYNJ2—breast cancer	2.89e-05	0.000431	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—KRAS—breast cancer	2.8e-05	0.000416	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—NDUFS3—breast cancer	2.71e-05	0.000404	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—NDUFS3—breast cancer	2.69e-05	0.0004	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—CTNNB1—breast cancer	2.67e-05	0.000397	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—MMP9—breast cancer	2.61e-05	0.000389	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—MED12—breast cancer	2.59e-05	0.000385	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CHST9—breast cancer	2.55e-05	0.00038	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CHST9—breast cancer	2.53e-05	0.000376	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—HRAS—breast cancer	2.5e-05	0.000372	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	2.47e-05	0.000368	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—COX11—breast cancer	2.42e-05	0.00036	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—SRC—breast cancer	2.41e-05	0.000359	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	2.41e-05	0.000358	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—COX11—breast cancer	2.4e-05	0.000357	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—IL6—breast cancer	2.4e-05	0.000356	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—HRAS—breast cancer	2.38e-05	0.000354	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	2.36e-05	0.000351	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—VEGFA—breast cancer	2.35e-05	0.000349	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—STAT3—breast cancer	2.32e-05	0.000346	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—breast cancer	2.29e-05	0.00034	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—IL6—breast cancer	2.28e-05	0.000339	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—MAPK3—breast cancer	2.22e-05	0.00033	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CDA—breast cancer	2.21e-05	0.000329	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—SHMT1—breast cancer	2.21e-05	0.000329	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—AKT1—breast cancer	2.21e-05	0.000329	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—SHMT1—breast cancer	2.19e-05	0.000326	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CDA—breast cancer	2.19e-05	0.000326	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	2.17e-05	0.000322	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—TGFB1—breast cancer	2.15e-05	0.000321	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	2.14e-05	0.000319	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—SLC2A5—breast cancer	2.13e-05	0.000317	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—SLCO1B1—breast cancer	2.13e-05	0.000317	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—EGFR—breast cancer	2.11e-05	0.000314	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—SLC2A5—breast cancer	2.11e-05	0.000314	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—SLCO1B1—breast cancer	2.11e-05	0.000314	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	2.06e-05	0.000307	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—APRT—breast cancer	2.06e-05	0.000306	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—APRT—breast cancer	2.04e-05	0.000303	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—TNF—breast cancer	2.01e-05	0.000299	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—FASN—breast cancer	2e-05	0.000298	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—KRAS—breast cancer	2e-05	0.000297	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—breast cancer	1.99e-05	0.000297	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ESRRA—breast cancer	1.93e-05	0.000288	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ANGPTL4—breast cancer	1.93e-05	0.000288	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ESRRA—breast cancer	1.92e-05	0.000285	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ANGPTL4—breast cancer	1.92e-05	0.000285	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GPI—breast cancer	1.83e-05	0.000273	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—HADHB—breast cancer	1.83e-05	0.000273	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	1.82e-05	0.000271	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GPI—breast cancer	1.82e-05	0.00027	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—HADHB—breast cancer	1.82e-05	0.00027	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ALDH7A1—breast cancer	1.75e-05	0.00026	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ALDH1A1—breast cancer	1.75e-05	0.00026	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	1.74e-05	0.000259	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ALDH7A1—breast cancer	1.73e-05	0.000258	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ALDH1A1—breast cancer	1.73e-05	0.000258	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	1.71e-05	0.000255	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—HRAS—breast cancer	1.7e-05	0.000252	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—UMPS—breast cancer	1.68e-05	0.00025	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—FHL2—breast cancer	1.68e-05	0.00025	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ADSL—breast cancer	1.68e-05	0.00025	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—NME1—breast cancer	1.68e-05	0.00025	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PHGDH—breast cancer	1.68e-05	0.00025	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—UMPS—breast cancer	1.66e-05	0.000247	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—NME1—breast cancer	1.66e-05	0.000247	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PHGDH—breast cancer	1.66e-05	0.000247	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ADSL—breast cancer	1.66e-05	0.000247	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—FHL2—breast cancer	1.66e-05	0.000247	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—LDHB—breast cancer	1.64e-05	0.000245	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—BRIP1—breast cancer	1.64e-05	0.000245	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—HPSE—breast cancer	1.64e-05	0.000245	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—HPSE—breast cancer	1.63e-05	0.000243	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—BRIP1—breast cancer	1.63e-05	0.000243	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—LDHB—breast cancer	1.63e-05	0.000243	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—IL6—breast cancer	1.62e-05	0.000242	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ABCC1—breast cancer	1.56e-05	0.000232	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—HMMR—breast cancer	1.56e-05	0.000232	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GSTA3—breast cancer	1.56e-05	0.000232	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GSTA3—breast cancer	1.55e-05	0.00023	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—HMMR—breast cancer	1.55e-05	0.00023	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ABCC1—breast cancer	1.55e-05	0.00023	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PPARGC1B—breast cancer	1.51e-05	0.000225	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—AKT1—breast cancer	1.5e-05	0.000223	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PPARGC1B—breast cancer	1.5e-05	0.000223	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	1.46e-05	0.000217	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	1.46e-05	0.000217	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GSTA4—breast cancer	1.43e-05	0.000212	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CA9—breast cancer	1.43e-05	0.000212	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GSTA4—breast cancer	1.41e-05	0.00021	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CA9—breast cancer	1.41e-05	0.00021	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—breast cancer	1.4e-05	0.000208	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GPX2—breast cancer	1.39e-05	0.000207	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GSTA2—breast cancer	1.39e-05	0.000207	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	1.38e-05	0.000206	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GSTA2—breast cancer	1.38e-05	0.000205	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GPX2—breast cancer	1.38e-05	0.000205	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GPX4—breast cancer	1.37e-05	0.000204	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—SULT1A1—breast cancer	1.37e-05	0.000204	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GPX4—breast cancer	1.36e-05	0.000202	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—SULT1A1—breast cancer	1.36e-05	0.000202	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—IDH1—breast cancer	1.34e-05	0.000199	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GSTA1—breast cancer	1.34e-05	0.000199	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—IDH1—breast cancer	1.33e-05	0.000198	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GSTA1—breast cancer	1.33e-05	0.000198	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—NAT2—breast cancer	1.33e-05	0.000197	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—NAT2—breast cancer	1.31e-05	0.000196	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—breast cancer	1.19e-05	0.000177	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—MED12—breast cancer	1.16e-05	0.000173	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—DPYD—breast cancer	1.16e-05	0.000173	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—MED12—breast cancer	1.15e-05	0.000171	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—DPYD—breast cancer	1.15e-05	0.000171	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ALDOA—breast cancer	1.14e-05	0.00017	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ALDOA—breast cancer	1.13e-05	0.000169	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—NCOA3—breast cancer	1.11e-05	0.000165	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—SLC2A2—breast cancer	1.1e-05	0.000164	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—NCOA3—breast cancer	1.1e-05	0.000164	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—SLC2A2—breast cancer	1.09e-05	0.000163	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.08e-05	0.000161	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ABCG2—breast cancer	1.08e-05	0.000161	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CPT1A—breast cancer	1.08e-05	0.000161	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—MTR—breast cancer	1.08e-05	0.000161	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ABCG2—breast cancer	1.07e-05	0.000159	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—MTR—breast cancer	1.07e-05	0.000159	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CPT1A—breast cancer	1.07e-05	0.000159	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—HPGDS—breast cancer	1.06e-05	0.000158	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—HBA1—breast cancer	1.05e-05	0.000157	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—HPGDS—breast cancer	1.05e-05	0.000156	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—HBA1—breast cancer	1.04e-05	0.000155	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ACHE—breast cancer	1.03e-05	0.000153	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GSTT1—breast cancer	1.03e-05	0.000153	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GSTT1—breast cancer	1.02e-05	0.000152	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ACHE—breast cancer	1.02e-05	0.000152	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CYP17A1—breast cancer	9.73e-06	0.000145	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CYP17A1—breast cancer	9.65e-06	0.000144	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PTGS1—breast cancer	9.63e-06	0.000143	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ENO1—breast cancer	9.63e-06	0.000143	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ENO1—breast cancer	9.55e-06	0.000142	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PTGS1—breast cancer	9.55e-06	0.000142	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	9.51e-06	0.000142	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	9.39e-06	0.00014	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CYP2D6—breast cancer	9.37e-06	0.000139	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—NCOA2—breast cancer	9.27e-06	0.000138	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—NCOA2—breast cancer	9.19e-06	0.000137	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—FASN—breast cancer	8.99e-06	0.000134	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—BCHE—breast cancer	8.96e-06	0.000133	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—FASN—breast cancer	8.92e-06	0.000133	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—BCHE—breast cancer	8.88e-06	0.000132	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—SLC5A5—breast cancer	8.85e-06	0.000132	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—SLC5A5—breast cancer	8.77e-06	0.00013	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—NQO1—breast cancer	8.54e-06	0.000127	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—SLC2A1—breast cancer	8.54e-06	0.000127	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—SLC2A1—breast cancer	8.47e-06	0.000126	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—NQO1—breast cancer	8.47e-06	0.000126	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CYP3A4—breast cancer	8.33e-06	0.000124	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	8.29e-06	0.000123	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CYP3A4—breast cancer	8.26e-06	0.000123	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	8.22e-06	0.000122	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CYP1B1—breast cancer	8.19e-06	0.000122	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CYP1B1—breast cancer	8.12e-06	0.000121	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—HSP90AA1—breast cancer	8.03e-06	0.00012	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—HSP90AA1—breast cancer	7.96e-06	0.000118	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—NCOA1—breast cancer	7.81e-06	0.000116	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—NCOA1—breast cancer	7.75e-06	0.000115	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—STK11—breast cancer	7.7e-06	0.000115	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CYP19A1—breast cancer	7.7e-06	0.000115	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—STK11—breast cancer	7.63e-06	0.000114	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CYP19A1—breast cancer	7.63e-06	0.000114	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	7.17e-06	0.000107	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—COMT—breast cancer	7.16e-06	0.000107	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GSTP1—breast cancer	7.13e-06	0.000106	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—COMT—breast cancer	7.1e-06	0.000106	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GSTP1—breast cancer	7.06e-06	0.000105	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—HMOX1—breast cancer	7.03e-06	0.000105	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ITPR1—breast cancer	7.01e-06	0.000104	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—HMOX1—breast cancer	6.97e-06	0.000104	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ITPR1—breast cancer	6.95e-06	0.000103	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ABCB1—breast cancer	6.75e-06	0.0001	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ABCB1—breast cancer	6.69e-06	9.95e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—TYMS—breast cancer	6.62e-06	9.86e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—TYMS—breast cancer	6.57e-06	9.77e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GSTM1—breast cancer	6.55e-06	9.74e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—NCOR1—breast cancer	6.55e-06	9.74e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PLA2G4A—breast cancer	6.55e-06	9.74e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GSTM1—breast cancer	6.49e-06	9.66e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—NCOR1—breast cancer	6.49e-06	9.66e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PLA2G4A—breast cancer	6.49e-06	9.66e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GPX1—breast cancer	6.27e-06	9.33e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GPX1—breast cancer	6.22e-06	9.25e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CYP1A1—breast cancer	6.21e-06	9.23e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ERCC2—breast cancer	6.16e-06	9.16e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CYP1A1—breast cancer	6.15e-06	9.16e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ERCC2—breast cancer	6.1e-06	9.08e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—MTHFR—breast cancer	5.79e-06	8.61e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—MTHFR—breast cancer	5.74e-06	8.54e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CAV1—breast cancer	5.34e-06	7.94e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CAV1—breast cancer	5.29e-06	7.87e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	5.06e-06	7.52e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PIK3CG—breast cancer	4.86e-06	7.23e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PIK3CG—breast cancer	4.82e-06	7.17e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PIK3CD—breast cancer	4.27e-06	6.36e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PIK3CD—breast cancer	4.24e-06	6.3e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ALB—breast cancer	4.22e-06	6.28e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ALB—breast cancer	4.18e-06	6.22e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—NOS3—breast cancer	4.04e-06	6e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—NOS3—breast cancer	4e-06	5.95e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PIK3CB—breast cancer	3.73e-06	5.54e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PIK3CB—breast cancer	3.69e-06	5.49e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PTGS2—breast cancer	3.69e-06	5.49e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PTGS2—breast cancer	3.66e-06	5.44e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PTEN—breast cancer	3.22e-06	4.79e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PTEN—breast cancer	3.19e-06	4.75e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PIK3CA—breast cancer	2.27e-06	3.38e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PIK3CA—breast cancer	2.25e-06	3.35e-05	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—AKT1—breast cancer	1.86e-06	2.76e-05	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—AKT1—breast cancer	1.84e-06	2.74e-05	CbGpPWpGaD
